These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 2887224)
1. 1986 update of HIV seroprevalence, seroconversion, AIDS incidence, and immunologic correlates of HIV infection in patients with hemophilia A and B. Ragni MV; Winkelstein A; Kingsley L; Spero JA; Lewis JH Blood; 1987 Sep; 70(3):786-90. PubMed ID: 2887224 [TBL] [Abstract][Full Text] [Related]
2. AIDS retrovirus antibodies in hemophiliacs treated with factor VIII or factor IX concentrates, cryoprecipitate, or fresh frozen plasma: prevalence, seroconversion rate, and clinical correlations. Ragni MV; Tegtmeier GE; Levy JA; Kaminsky LS; Lewis JH; Spero JA; Bontempo FA; Handwerk-Leber C; Bayer WL; Zimmerman DH Blood; 1986 Mar; 67(3):592-5. PubMed ID: 3081062 [TBL] [Abstract][Full Text] [Related]
3. Coincidental appearance of LAV/HTLV-III antibodies in hemophiliacs and the onset of the AIDS epidemic. Evatt BL; Gomperts ED; McDougal JS; Ramsey RB N Engl J Med; 1985 Feb; 312(8):483-6. PubMed ID: 2982095 [TBL] [Abstract][Full Text] [Related]
4. Geographic differences in hemophilia-associated AIDS incidence in Pennsylvania. By the Pennsylvania AIDS Surveillance Study Group. Blood; 1987 Oct; 70(4):1208-10. PubMed ID: 3115336 [TBL] [Abstract][Full Text] [Related]
5. Clinical, immunological, and virological aspects in Japanese hemophiliacs and AIDS patients. Abe T AIDS Res; 1986 Dec; 2 Suppl 1():S141-6. PubMed ID: 3103637 [TBL] [Abstract][Full Text] [Related]
6. Lymphadenopathy-associated virus antibodies and T cells in hemophiliacs treated with cryoprecipitate or concentrate. Gjerset GF; McGrady G; Counts RB; Martin PJ; Jason J; Kennedy S; Evatt B; Hansen JA Blood; 1985 Sep; 66(3):718-20. PubMed ID: 2992642 [TBL] [Abstract][Full Text] [Related]
7. Determinants of progression of HIV infection in a Greek hemophilia cohort followed for up to 16 years after seroconversion. Touloumi G; Karafoulidou A; Gialeraki A; Katsarou O; Milona I; Kapsimali V; Mandalaki T; Hatzakis A J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Sep; 19(1):89-97. PubMed ID: 9732075 [TBL] [Abstract][Full Text] [Related]
8. HTLV III antibodies and immunological alterations in hemophilia patients. Seifried E; Pindur G; Stötter H; Porzsolt F; Rasche H; Erfle V; Hehlmann R; Heimpel H Klin Wochenschr; 1986 Feb; 64(3):115-24. PubMed ID: 3005759 [TBL] [Abstract][Full Text] [Related]
9. Detection of antibody to LAV/HTLV-III in sera from hemophiliacs in China. Zeng Y; Fan J; Zhang Q; Wang PC; Tang DJ; Zhon SC; Zheng XW; Liu DP AIDS Res; 1986 Dec; 2 Suppl 1():S147-9. PubMed ID: 3103638 [TBL] [Abstract][Full Text] [Related]
10. Antibodies to HIV in Israeli hemophiliacs: relationship between serological profile and disease development. Orgad S; Malone G; Zaizov R; Marinowitz U; McLane MF; Umiel T; Cohen IJ; Vogel R; Cohen-Avishai O; Ramot B AIDS Res Hum Retroviruses; 1987; 3(3):323-32. PubMed ID: 3124874 [TBL] [Abstract][Full Text] [Related]
11. The spectrum of human immunodeficiency virus infection in patients with factor IX deficiency (Christmas disease). Goldsmith JM; Variakojis D; Phair JP; Green D Am J Hematol; 1987 Jun; 25(2):203-10. PubMed ID: 3037883 [TBL] [Abstract][Full Text] [Related]
12. Factors associated with progression to AIDS and mortality in a cohort of HIV-infected patients with hemophilia followed up since seroconversion. Santagostino E; Gringeri A; Cultraro D; Tradati F; Siracusano L; Marinoni A; Mannucci PM Cell Mol Biol (Noisy-le-grand); 1995 May; 41(3):371-80. PubMed ID: 7580830 [TBL] [Abstract][Full Text] [Related]
13. Immunologic aberrations, HIV seropositivity and seroconversion rates in patients with hemophilia B. Brettler DB; Brewster F; Levine PH; Forsberg A; Baker S; Sullivan JL Blood; 1987 Jul; 70(1):276-81. PubMed ID: 3109524 [TBL] [Abstract][Full Text] [Related]
14. Distribution of the level of antibody to AIDS-associated virus (LAV) in sera from AIDS or AIDS related complex and Japanese hemophiliacs infected with AIDS-associated virus. Tsuchie H; Kawatani T; Nakayama E; Matsui T; Kurimura T; Hinuma Y Microbiol Immunol; 1985; 29(11):1083-7. PubMed ID: 2869397 [TBL] [Abstract][Full Text] [Related]
16. HTLV-III status and abnormalities in T lymphocyte distribution in children with hemophilia A. Shannon BT; Roach J; Cheek-Luten M; Ruymann FB Diagn Immunol; 1986; 4(1):37-42. PubMed ID: 3006971 [TBL] [Abstract][Full Text] [Related]
17. Seroconversion to human immunodeficiency virus (HIV) in hemophiliacs. Relation to lymphadenopathy. Andes WA; Daul CB; deShazo RD; Palmer CH Transfusion; 1988; 28(2):98-102. PubMed ID: 3127971 [TBL] [Abstract][Full Text] [Related]
18. HIV seroconversion in Swedish haemophiliacs: relation to type and dosage of factor concentrate. Berntorp E; Hansson BG; Böttiger B; Jarevi G; Wedbäck A; Nordenfelt E; Nilsson IM Eur J Haematol; 1987 Mar; 38(3):256-60. PubMed ID: 3109938 [TBL] [Abstract][Full Text] [Related]
19. Human immunodeficiency virus infection in hemophiliac patients. A three-year prospective evaluation. Daul CB; deShazo RD; Andes WA Am J Med; 1988 May; 84(5):801-9. PubMed ID: 3163229 [TBL] [Abstract][Full Text] [Related]
20. [Follow-up study of HIV-I antigen (p 24) and HIV-I antibody (gp 41, p 24) in hemophiliacs with HIV-I infection]. Mimaya J; Toyoda Y; Tonouchi T; Sugiyama T Rinsho Ketsueki; 1988 Jun; 29(6):795-801. PubMed ID: 2901502 [No Abstract] [Full Text] [Related] [Next] [New Search]